移植排斥 的英文怎麼說

中文拼音 [zhíbèichì]
移植排斥 英文
graft rejection
  • : Ⅰ動詞1. (移動) move; remove; shift 2. (改變; 變動) change; alter Ⅱ名詞(姓氏) a surname
  • : Ⅰ動詞1. (栽種) plant; grow; cultivate 2. (樹立) establish; set up Ⅱ名詞(姓氏) a surname
  • : 排構詞成分。
  • : Ⅰ動詞1 (責備) upbraid; scold; blame; reproach; denounce; reprimand 2 (驅逐; 排斥; 使離開) rep...
  • 移植 : 1. [農業] (移苗) transplant 2. [醫學] (機體移植) transplanting; grafting; removal
  • 排斥 : repel; exclude; reject; eject; discriminate against; repulsion; aversion
  1. Unlilie other cells that also use the salvage pathway for purine biosynhesis, prolfferating b and t cells are solely dependent on the de novo pathway for the generation of wsine. by blocking impdh, b and t cells cannot synthesise the necessary levels of ana and dna to molm a proliferathe response to ags and ndogens

    根據對balb c和c57bl 6小鼠互為供、受者進行的結果表明,在發生時間上不同的鼠株組合存在差異b 0刀勻, balb兒小鼠的同種應答強度較c57bl 6小鼠為弱。
  2. Answer : special disease includes the following range : ( one ) the outpatient service of malignant tumor puts cure, change cure ; ( 2 ) the outpatient service that chronic kidney merit fails is dialytic ; ( 3 ) after kidney transplant art fight repulsion to medication ; ( 4 ) chronic leukaemia ; ( 5 ) aplastic anemia ; ( 6 ) pajinsen disease ; ( 7 ) lupus erythematosus ; ( 8 ) liver is sclerotic ; ( 9 ) schizophrenia ; ( 10 ) other must undertake outpatient service medications uninterruptedly for a long time ( be like hypertensive, diabetic etc ), and cost of drug of every quarter outpatient service exceeds worker of the year on this city the disease of 15 % above plants average wage

    答:非凡疾病包括以下范圍: (一)惡性腫瘤的門診放療、化療; (二)慢性腎功衰竭的門診透析; (三)腎術后的抗藥物治療; (四)慢性白血病; (五)再生障礙性貧血; (六)帕金森氏癥; (七)紅斑狼瘡; (八)肝硬化; (九)精神分裂癥; (十)其他必須長期不間斷地進行門診藥物治療(如高血壓、糖尿病等) ,並且每季度門診藥品費用超過本市上年度職工平均工資15 %以上的病種。
  3. As a whole fund is used at paying rescue of be in hospital, emergency call, malignant tumor outpatient service to put ( change ) function of cure, chronic kidney is not complete outpatient service outpatient service of dialytic, cataract is supersonic the medical treatment fee that examine of back door of emulsification and viscera official transplanting uses the medicaments place that fights repellent reaction to happen

    統籌基金用於支付住院、急診搶救、惡性腫瘤門診放(化)療、慢性腎功能不全門診透析、白內障門診超聲乳化及臟器官后門診使用抗反應的藥物所發生的醫療費。
  4. Rejection spoils the record of corneal grafts.

    反應影響了角膜的效果。
  5. The hand transplant recipient, new zealander clint hallam, later had it amputated. doctors said he failed to take the required drugs and his body rejected the limb

    手術后,因為哈勒姆沒有按要求服用必須的藥物及他的身體對器官產生了反應,最後不得不將的器官切除掉。
  6. Conclusion : mast cells may be involved in the chronic rejection of kidney transplantation and its mechanism remains to be studied

    結論:肥大細胞可能參與了腎移植排斥反應,其作用機理尚需進一步研究。
  7. Also used to treat organ transplant recipients to help prevent graft rejection

    也用於器官者幫助防止
  8. The inhibitory effect of tlsfjm on rat cardiac allograft rejection

    抑制大鼠心臟移植排斥反應的作用
  9. Prevention and treatment of host rejection a pre - requisite for successful transplantation of donor tissue and stein cells

    摘要影響異體角膜緣角膜緣幹細胞術成敗的關鍵是術后移植排斥反應的防治。
  10. Expression and significance of programmed death ligand - 1 and programmed death - i in the renal tissues following acute rejection after kidney transplantation

    1在急性腎移植排斥患者腎組織中的表達及意義
  11. It is suggested that the monitoring of shla - i is very important to evaluate the effect of rejection episide for renal transplant recipients

    動態監測可溶性hla i能預示腎移植排斥的發生,對治療效果的判斷也有一定價值。
  12. Dendritic cel1s ( dcs ) are highly potent anigenpresenting cells of bone marrow origin that can stbolate both primary and secondary t - and b - cell responses

    Dc是唯一能夠激活初始型t細胞的apc ,具有激活移植排斥反應的作用。
  13. Graft rejection reflects a cascade of eents ranging from inductie eents in lymphoid tissue through cell migration, tissue entry and then damage

    移植排斥表現為一系列級聯性反應事件,包括淋巴組織中細胞發生行的誘發性事件,到進入組織,隨后產生傷害作用的反應。
  14. Skin is the most rejected transplantable tissue in the body and the rcs group estimated that between 30 and 50 per cent of face transplants could result in problems within fie years

    皮膚是體內最容易發生移植排斥的組織,皇家外科醫師學會研究團隊評估將有30 50的臉在5年內會出現問題。
  15. Backgroud : the activation of antigen - specific t cells plays a vital role in the initiation and development of some immune - related diseases, such as transplant rejection and allergic diseases

    背景:抗原特異性t細胞的活化在一些免疫相關疾病(如移植排斥反應、變應性疾病)的發生、發展中起著主導性的作用。
  16. This study summarized mechanisms, clinical findings, early diagnosis of host tissue rejection against keratolimbal allograft / corneal limbal stem cells and the possible prevention and treatment measures

    在參閱有關文獻后,本文對術后移植排斥反應的機制、表現及早期診斷和處理方法等諸多方面進行了較為全面的綜述。
  17. Recombinated human ctla4ig fusion protein had been used experimentally and clinically in prevention and treatment of transplant rejection, autoimmune diseases and allergic diseases, and positive curiative results were obtained

    重組人ctla4ig融合蛋白已被運用於防治移植排斥反應、自身免疫性疾病和變應性疾病等的實驗和臨床研究,並取得了肯定的效果。
  18. Hence, yeast gs115 was used to express the target protein in this study. objection : to obtain the biological activated recombianated protein of huaman ctla4 extracellular domain ( ctla4e ), and to explore its effects on allergic diseases and transplant rejection

    目的:獲取具有生物學活性的重組人ctla4胞外區蛋白( ctla4e ) ,探討其在變應性疾病和器官移植排斥反應防治中的作用和機理。
  19. Although the development of relatively non - toxic immunosuppressive or tolerance - inducing regimens will be required to justify clinical trials using pig organs, recent advances in our understanding of the biology of xenograft rejection and zoonotic infections, and the generation of alpha1, 3 - galactosyltransferase - deficient pigs have moved this approach closer to clinical application

    盡管用豬的器官進行臨床試驗尚有賴于相對無毒的免疫抑制劑或致耐方法的發展,但是我們在異種移植排斥反應及豬源人畜共患病等方面生物學知識的進步,以及1 , 3半乳糖轉酶缺陷豬的產生,已經使異種離臨床應用更近了一步。
  20. Although the deelopment of relatiely non - toxic immunosuppressie or tolerance - inducing regimens will be required to justify clinical trials using pig organs, recent adances in our understanding of the biology of xenograft rejection and zoonotic infections, and the generation of alpha1, 3 - galactosyltransferase - deficient pigs hae moed this approach closer to clinical application

    盡管用豬的器官去驗證臨床試驗需要相對無毒的免疫抑制劑或致耐的方法,但隨著近來我們對異種移植排斥生物學及動物傳染病感染的深入理解,以及1 , 3半乳糖轉酶缺陷豬的產生,異種更接近臨床應用。
分享友人